PaxVax, Army Launch Phase I Clinical Trials of Updated Adenovirus Vaccine
PaxVax has begun the initial phase of clinical trials of an updated version of a three-decade-old vaccine against Adenovirus Serotypes 4 and 7 that cause acute respiratory distress that leads to severe pneumonia and hospitalization and occurs in military training centers. The company said Monday it has collaborated with the U.S. Army Medical Materiel Development […] More